Highlights
1 patent
About
Mitral Regurgitation Solution
MValve technologies is dedicated to providing a solution for mitral regurgitation, an abnormal reversal of blood flow from the hearts left ventricle to the left atrium.
Identity
| Name | MValve technologies |
|---|---|
| Slug | mvalve-technologies |
| Type / kind | startup |
| Crunchbase ID | mvalve-technologies |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6ZsccKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Oct 2018 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Herzliya |
| HQ address | Medinat HaYehudim Street 91, Herzliyya, Israel |
Web & social
| https://www.linkedin.com/company/3190198 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesLife SupportMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
surgerycardiologyvalvesmedical-devicesmedical-technologieshospitals
Funding
| Total raised | $200.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}